Translating the molecular message of triple-negative breast cancer into targeted therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25351747.
- Also identified by DOI 10.1158/1078-0432.CCR-14-2532.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Triple-negative breast cancer (TNBC) has a poor prognosis with limited treatment options. Genomic analysis of TNBCs offers the opportunity to decode TNBC into biologically relevant subtypes with unique molecular targets. With further research, these findings may be translated into effective targeted therapeutic options.
Medical subject headings
- Transcriptome
- Triple Negative Breast Neoplasms